Home/Filings/4/0001127602-24-005355
4//SEC Filing

Bancel Stephane 4

Accession 0001127602-24-005355

CIK 0001682852other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 4:10 PM ET

Size

9.0 KB

Accession

0001127602-24-005355

Insider Transaction Report

Form 4
Period: 2024-02-14
Bancel Stephane
DirectorChief Executive Officer
Transactions
  • Sale

    Common Stock

    2024-02-16$88.88/sh26,351$2,342,0985,460,224 total
  • Award

    Common Stock

    2024-02-14+56,7365,486,575 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    9,050,372
  • Common Stock

    (indirect: See Footnote)
    6,564,880
Footnotes (4)
  • [F1]These shares are owned directly by Boston Biotech Ventures, LLC ("Boston Biotech"). The reporting person is the majority equity unit holder and the sole managing member of Boston Biotech. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
  • [F2]These shares are owned directly by OCHA LLC ("OCHA"). The reporting person is the majority equity unit holder and the sole managing member of OCHA. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
  • [F3]The reported transaction is the vesting of performance-based restricted stock units granted to the reporting person on March 5, 2021 (the "2021 PSUs").
  • [F4]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the 2021 PSUs. This "sell-to-cover" transaction was mandated by the Issuer's equity incentive plan and does not represent a discretionary trade by the reporting person.

Issuer

Moderna, Inc.

CIK 0001682852

Entity typeother

Related Parties

1
  • filerCIK 0001443340

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 4:10 PM ET
Size
9.0 KB